The Moderna sign is visible outside their headquarters in Cambridge, Massachusetts on March 11, 2021.
Boston Globe | Getty Images
Moderna shares tumbled 8% on Thursday after the company cut its annual Covid-19 vaccine sales forecast to $ 15-18 billion from $ 20 billion.
This is an evolving story. Please stay tuned.